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E26 transformation-specific (Ets) family of transcription factors are characterized by
the presence of Ets-DNA binding domain and have been found to be highly involved
in hematopoiesis and various tissue differentiation. ESE-1, or Elf3 in mice, is a
member of epithelium-specific Ets sub-family which is most prominently expressed in
epithelial tissues such as the gut, mammary gland, and lung. The role of ESE-1 during
embryogenesis had long been alluded from 30% fetal lethality in homozygous knockout
mice and its high expression in preimplantation mouse embryos, but there has been no
in-depth of analysis of ESE-1 function in early development. With improved proteomics,
gene editing tools and increasing knowledge of ESE-1 function in adult tissues, we hereby
propose future research directions for the study of ESE-1 in embryogenesis, including
studying its regulation at the protein level and at the protein family level, as well as better
defining the developmental phase under investigation. Understanding the role of ESE-1
in early development will provide new insights into its involvement in tissue regeneration
and cancer, as well as how it functions with other Ets factors as a protein family.
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INTRODUCTION
E26 transformation-specific (Ets) transcription factors are characterized by the presence of
conserved Ets-DNA binding domain which recognizes a core sequence of GGAA/T, consisting a
protein family of at least 27 members in human and 26 in mice (Bult et al., 2008; Hollenhorst et al.,
2011). Numerous studies in cell lines and gene disruption animal models have identified function
of individual ETS factors as well as their evolutionary relationships, which are reviewed elsewhere
(Bartel et al., 2000; Sharrocks, 2001; Oikawa and Yamada, 2003; Gutierrez-Hartmann et al., 2007).
However, most studies have focused on single-protein analysis or in vitro DNA binding assays that
do not reveal Ets proteins acting in vivo (Sementchenko and Watson, 2000), when global analyses
of Ets factors have revealed that over 16 of Ets members are co-expressed in a given cell type and
more than 8 ubiquitously so (Hollenhorst et al., 2004). The potential Ets targets can extensively
overlap (Hollenhorst et al., 2007) due to the conservation of mode and specificity of the Ets-DNA
binding domain (Sharrocks, 2001; Wei et al., 2010).
Ets factors have been divided into four sub-groups by difference in preferred Ets-binding motifs,
which were determined by variations in amino-acids that interact with the backbone of the core
recognition sequence (Wei et al., 2010). Nevertheless, there is still redundancy within sub-groups
with factors binding to the same cognition signal. Class I factors, for example, include at least 11
Ets factors and mainly recognize CCGGAA/T, while Class III factors, which include ESE-1 and at
least 5 others, demonstrate strong preference for GCGGAAC (Wei et al., 2010). Therefore, other
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determinants of specificity, such as protein-protein interactions
with other transcription factors via distinct protein domains
and additional regulatory sequences flanking the core Ets-
binding site on target genes, are as important to recognize
how Ets factors function as a family within a cell. This
means that manipulation of a single Ets factor may result in
a mitigated phenotype due to functional compensation from
other members. This particularly applies to embryogenesis,
where some Ets factors have been shown to be redundant
(Kageyama et al., 2006). Therefore, more holistic approaches are
required to understand the interplay of Ets factors during early
development.
In this Perspective, we focus on a well-characterized member
of a subfamily of Ets factors called ESE-1, or Epithelium-specific
Ets transcription factor 1, to provide an overall direction of future
research on ESE-1 and other Ets factors in fetal development.
ESE-1 homolog in mice is known as Elf3. Epithelial-specific
Ets factors, or ESEs, constitute a subfamily of Ets factors
which include ESE-1/Elf3, ESE-2/Elf5, ESE-3/Ehf, and PDEF,
whose expression patterns are known to be mostly restricted
to epithelial tissues (Sharrocks, 2001). The role of ESE-1 is
more thoroughly reviewed elsewhere (Oliver et al., 2012), and
has been studied primarily in epithelium differentiation. ESE-
1 therefore has received less attention regarding its role in
early development, despite evidence suggesting its involvement
as discussed below. With recent advances in proteomics and
genomics as well as gene editing tools such as CRISPR/Cas, it
is time to build more knowledge on how ESE-1 is modulated
at protein level and how it functions in combination with
other Ets factors during embryogenesis. Analysis of Ets intra-
family interaction and regulation during embryogenesis will
provide better insight into other protein families that are likewise
comprised of multiple and redundant members such as HOX,
GATA, and FOX proteins which share highly similar DNA-
binding domains (Messina et al., 2004), as well as providing
functional insight into the role of ESE-1 in cancer and tissue
regeneration.
THE ROLE OF ESE-1 IN EMBRYONIC
DEVELOPMENT
The involvement of ESE-1 in early development was first
identified in the diminished survival of Elf3 homozygous
knockout mice, where targeted deletion of Elf3 resulted in 30%
of fetal lethality at around embryonic day 11.5 (E11.5) (Ng
et al., 2002). However, no gross histopathological anomalies
were found to explain the cause of death (Ng et al., 2002).
Similarly, disruption of Elf3 by siRNA injection reduced embryo
survival by 50%, while co-suppression of three prominent
Ets factors expressed in mouse preimplantation embryos
Elf3, Etsrp71, and Spic blocked development to blastocysts by
70%, involving reduction of key regulatory genes eIF-1A and
Oct3/4 that contain Ets-binding sites (EBS) in their promoters
(Kageyama et al., 2006). Recent reports have also shown
inhibitory effect of ESE-1 on stem cell transcription factor
Oct4 expression by binding to EBS in the conserved region 2
(CR2) of the Oct4 promoter during retinoic acid (RA)-induced
differentiation of human embryonic carcinoma cell line NCCIT
(Park et al., 2014). Oct4 is essential in the maintenance of
stem cell pluripotency and its loss of expression leads to
cell differentiation (Pan et al., 2002). Therefore, the inverse
relationship between Elf3 and Oct4 and the close involvement
of ESE-1 in epithelial cell differentiation in various tissue
types such as skin, small intestine and mammary gland may
indicate that ESE-1 is a marker of epithelial tissue development.
However, the exact gene targets or functional mechanism
of ESE-1/Elf3 during early development have not been
elucidated.
REGULATION OF ESE-1 EXPRESSION
Promoter analysis of ESE-1 has revealed four main regulatory
regions Ets, CAAT, TATA, and NFκB (Oettgen et al., 1999).
However, different regions of the upstream segments of ESE-1
gene may be more critical than others during development and
differentiation. For example, Hou et al. demonstrated that in
retinoic acid-differentiated murine embryonal carcinoma (EC)
cell line F9, there is a substantial increase in the utilization of
an upstream regulator region approximately 2 kb upstream of
the transcription start site that was responsible for the increase
in the ESE-1 promoter site (Hou et al., 2004). While it is
well-known that long-range enhancers have important role in
mammalian gene regulation (Heintzman and Ren, 2009), factors
which bind to the enhancer region of ESE-1 gene have not been
well-defined. A conserved 30 base pair (bp) ESE-1 enhancer
sequence (ESS) was also shown to be essential in regulating
ESE-1 transcription in response to epithelial differentiation
signals, controlled by two ESS-binding protein complexes that
are of uncertain identity (Neve et al., 2006). In mouse embryo,
elf3 has been shown to be expressed at low levels in mouse
meiosis II (MII) oocytes, and increase at one-cell stage embryo,
briefly decline at the two-cell stage, and increase again until
the blastocyst stage (Kageyama et al., 2006). Therefore, more
investigation is needed to elucidate the ESE-1 enhancer elements
and their binding nuclear factors, as well as signals which
activate ESE-1 gene transcription during embryogenesis. The
most notable regulator of ESE-1 so far known is NFκB, which
is required for ESE-1 induction in response to pro-inflammatory
cytokines (Rudders et al., 2001; Wu et al., 2008). Whether this
applies to embryogenesis, however, is unknown. Additionally,
ESE-1 has been shown to downregulate its own cytokine-
induced expression (Wu et al., 2008), possibly by auto-inhibition
through intramolecular interaction between the N-terminal
transactivation domain and the C-terminal ETS domain (Kopp
et al., 2007). Other non-transcriptional mechanisms of regulation
of ESE-1, such as through microRNAs (Di et al., 2014; Qin et al.,
2015) has never been explored. Modern molecular techniques
such as long range interactions (4C experiments) (Cai et al.,
2016) or knock-down of specific transcription factors motifs
on the promotor and enhancers of ESE-1 using CRISPR/Cas9
may reveal interesting information about ESE-1 regulation in the
future.
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BUILDING AN OVERALL PICTURE AND
APPROACHES FOR THE FUTURE
As mentioned above, there is dearth of information on the exact
role of ESE-1 during embryogenesis, despite evidence suggesting
its involvement during blastocyst formation and organogenesis.
We therefore outline three main future research objectives for the
study of ESE-1 function during early development:
Better Analysis of ESE-1 Function at the
Protein Level
Most expression analysis on parts of mouse embryo for the
expression of ESE-/elf3 and ESE-3/ehf in different tissues have
so far focused on quantifying levels of mRNA, by Northern
blot or RT-PCR of isolated tissues and cell lines. Since there
has not been a longitudinal analysis of expression during mouse
embryonic development, we assessed the mRNA levels of ESE-
1/Elf3 and ESE-3/Ehf, whose Ets domain is 84% identical to ESE-1
Ets domain (Kas et al., 2000), in wild-type (WT) mice during
E7.5-E18.5 by limited cycle RT-PCR as a preliminary analysis
(Figure 1A). Albeit with varying degrees, we found that most of
the Elf3 and Ehf expression occurred between E13.5 and E18.5
during active organogenesis and tissue differentiation and in E7.5
following gastrulation (Loebel et al., 2003; Tam and Loebel, 2007;
Takaoka and Hamada, 2012). Further analysis by quantitative
RT-PCR may help confirm and quantify these expression levels.
However, RNA-based studies are limited in that they identify
transcriptional changes that are regulated both directly and
indirectly (Sementchenko and Watson, 2000), and that they do
not reveal protein modulations which may be more functionally
relevant, by mechanisms such as protein-protein interactions
and post-translational modifications that alter protein activity or
stability. It is understandable that there has been lack of high
quality antibodies which could recognize Ets factors of interest
in the past. However, with increased availability of better ESE-
1 antibodies and proteomic tools (Sydor and Nock, 2003; Pauly
et al., 2013), it is time to delve into studying the expression and
function of ESE-1/Elf3 at protein level.
One of the important determinants of Ets specificity is
tissue expression pattern (Hollenhorst et al., 2004; Wei et al.,
FIGURE 1 | Expression of ESE-1/Elf3 and ESE-3/Ehf during mouse embryogenesis. (A) Limited cycle RT-PCR analysis of Elf3 and Ehf gene expression. Total
mRNA from whole mouse embryo were collected at indicated time points of development (Left Panel), as well as from individual organs (Right Panel) such as lung
(L), salivary gland (S), kidney (K), gut (G), brain (B), skeletal muscle (SK), and Pancreas (P). The isolated mRNA were subjected to limited cycle RT-PCR analysis across
different time points ranging from Embryonic Day (E) 7.5–18.5. GAPDH gene was included as an internal control. RT-PCR products from each data point were loaded
onto agarose gel to visualize their size and intensity. Six to eight embryos were collected at early data points (E7.5-E10.5), and data shows n > 3 for each data point.
(B) RT-qPCR of various Ets factors in wild-type and Elf3−/− adult mouse lung. The graph shows n = 4–6 per data point, and statistical analysis was done by
two-tailed Student t-test with Welch’s correction where appropriate. “ns” indicates not significant; * and ** indicates P < 0.05 and P < 0.01, respectively.
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2010). However, there has been no comprehensive study
on the localization of Ets proteins during development, and
known facts on ESE-1 expression have been derived from
Northern blot analysis on human fetal tissues (Oettgen et al.,
1997), and E19 mouse embryo tissues (Tymms et al., 1997).
Therefore, immunohistochemistry of Elf3 in fixed mouse fetus
over the time course of development may be a good starting
point to get better understanding of ESE-1 protein expression
and its tissue distribution pattern. Understanding protein
expression and modulation will provide stepping stones to
ascertaining ESE-1 function and regulation at the protein
level. Additionally, Ets factors are known to undergo various
post-translational modifications such as phosphorylation,
glycosylation, ubiquitination, sumoylation, and acetylation
(Tootle and Rebay, 2005). Post-translational modification
can influence protein activity, protein-protein interactions,
protein-DNA interactions, subcellular localization, and stability,
thus significantly increasing the functional versatility of a
protein (Tootle and Rebay, 2005). The most promising post-
translational modification in ESE-1 is phosphorylation, where
ESE-1 has previously been shown to be stabilized by serine
phosphorylation, which altered its subcellular localization
and protein half-life in breast cancer (Manavathi et al., 2007).
NetPhos2.0 server predicts 15 potential serine phosphorylation
sites on ESE-1 protein with P-score of>0.95. Thus, whether ESE-
1 is post-translationally modified during embryogenesis should
be further investigated, and the development of phospho-ESE-1
antibody may help in functional analysis of phosphorylated
ESE-1.
ESE-1/Elf3 is also unique to the family of Ets factors that
it contains two AT-hook domains which can potentially enable
ESE-1 to bind in the minor groove of AT-rich DNA and interact
with other proteins (Kopp et al., 2007). Protein binding partners
have been shown to be critical in regulating Ets factor function
(reviewed in Li et al., 2000), but there is limited literature on
ESE-1 binding partners, only identified through GST-pull down
assays or immunoprecipitations in cell lines such as endothelial
cells and 293T cell line (Rudders et al., 2001; Longoni et al.,
2013). Therefore following identification and characterization
of ESE-1/Elf3 protein expression during embryogenesis, mass
spectrometric analysis of embryonic proteins (Nagano et al.,
2005) altered in Elf3−/− embryonic stem cells (ES) and
co-immunoprecipitated binding partners in WT mouse ES
nuclear extract (Liang et al., 2008) will provide great insights
into its function during early development through protein
interaction.
Better Analysis of ESE-1 Function As a
Member of the Ets Protein Family
Identification Ets target genes has mostly been derived from
gain or loss of function studies. Single knockout animal
models have been useful in revealing function of individual Ets
factors by distinct phenotypes (Bartel et al., 2000). However,
there has been virtually no in-depth analysis of changes in
other Ets factor expression or post-translational modifications,
while studies indicate that over two-thirds of Ets family
members are co-expressed in most cell types (Hollenhorst et al.,
2004). Notably, Ets factors are expressed temporally during
differentiation, showing sharp transitions in expression that
correlate with critical commitment (Anderson et al., 1999) or
growth events (Bhat et al., 1987), and distinct pattern of co-
expression during tumorigenesis (Galang et al., 2004). Therefore,
understanding this combinatorial nature of Ets family members
is essential in identifying the physiological function of Ets factors
in vivo.
Ets factors are known to physically and functionally interact
with each other, such as the binding between Tel and Fli-1
(Kwiatkowski et al., 1998) and between Ets2 with Ets1 and Erg
(Basuyaux et al., 1997). Analysis of other Ets factors in Elf3 KO
mouse lungs also revealed upregulation of other Ets factors in
the absence of Elf3, notably Erm (Figure 1B). One approach to
studying the interplay between other Ets factors, therefore, would
be to examine changes in expression and protein activity of other
Ets factors in homozygous knockout mice of a single or double
Ets gene(s), thus identifying possible source of compensation
from other Ets family members. High-throughput analyses of
transcriptional binding specificities have already been shown to
be more physiologically relevant than single-protein studies, as
exemplified by comparison study of homeobox protein family
(Wei et al., 2010). This similarly applies to revealing tissue-
specific interactions of Ets proteins, where examples of Ets family
interaction have shown tissue-dependent functional redundancy
of Ets factors. For example, in Ets2 knockout mice, Ets1 along
with other gene targets such as MMP3, MMP9, and uPA are
reduced in skin but unchanged in mammary gland (Yamamoto
et al., 1998). Protein microarrays are available for tissue-specific
interactions (Poetz et al., 2005; Stoll et al., 2005; Dominguez et al.,
2008), and initial analyses of tissue expression pattern would be
critical to guide this investigation.
For ESE subfamily, ESE-1 and ESE-3 are known to be
expressed mostly in the epithelium in both fetal and adult
tissues (Kas et al., 2000; Tugores et al., 2001; Silverman et al.,
2002), and ESE-1 has been shown to upregulate ESE-3 during
inflammation (Wu et al., 2008). To study whether ESE-1 and
ESE-3 expression therefore overlap during embryogenesis, we
performed in situ hybridization of the gut, lungs, and salivary
glands as representative tissues for ESE-1 and ESE-3 expression.
Interestingly, we found a differential pattern of expression in
the two ESEs where ESE-1 was more predominantly expressed
in the gut compared to ESE-3 (Figure 2A), and ESE-3 being
slightly more robust in the lungs (Figure 2B), and both ESE’s
were present at similar levels in the salivary gland (Figure 2C).
Therefore, conclusions drawn from one study using different cell
type and condition may not apply to other tissue models, and
specific definition of experimental context is vital to study Ets
factors during early development as discussed further below.
Better Definition of the Physiological
Context
Embryogenesis and fetal development consist of multiple steps
which involve rapid changes in cellular symmetry, position,
survival, and differentiation at the whole organismal level. The
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FIGURE 2 | In situ hybridization of Elf3 and Ehf for tissue localization during development. In situ hybridization was performed as previously described in Hui
and Joyner (1993). Mouse Elf3 full length cDNA plasmid was used as template for the digoxygenin-labeled RNA probe. Elf3 and Ehf were detected in (A) Gut, (B)
Lung, and (C) Salivary gland with anti-sense probe as a negative control. Pictures were taken at different time points from Embryonic Day (E) 14.5–18.5. Figure shows
a representative result from n > 3 mice for each data point.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 June 2016 | Volume 4 | Article 73
Lee et al. ESE-1 in Early Development
microenvironment of a cell, such as stem cell niche, has a
critical impact on the cellular developmental potential and
differentiation (Martinez-Agosto et al., 2007; Lane et al., 2014).
Therefore, precise definition of the developmental phase of
interest is important to more accurately represent the particular
in vivo microenvironment in vitro. Determination of specific
time point and tissue context during development, instead of
generic differentiation models using embryonic carcinoma cell
lines (Hou et al., 2004; Park et al., 2014), will thus be more
informative in designing in vitro models representative of the
developmental stage of interest to study the role of ESE-1 during
embryogenesis, and relate the information back to the in vivo
setting.
Previous findings on ESE-1 provide hints to the most
promising time points and tissue settings to focus on.
Hierarchical clustering of the transcriptome over the time course
of embryonic development, for example, revealed that E11.5-
E12.0, during which Elf3−/− embryos show partial fetal lethality,
is associated with dramatic induction of genes involved in adult
hemoglobin production and erythrocyte differentiation (Wagner
et al., 2005). The transcription of the beta hemoglobin chain
starts at E12.0, including other genes involved in hemoglobin
biosynthesis such as erythroid associated differentiation factor
(ERAF), and heme binding protein 1 (HEBP1) (Wagner et al.,
2005). Also, E11.5-E12.0 is the critical time point where
definitive hematopoiesis begins in the liver (Wagner et al.,
2005). Therefore, defects in hemoglobin synthesis may have been
partially responsible for embryonic lethality in Elf3−/− mice, and
studying the effect of ESE-1 deletion by genome editing (Peters
et al., 2008; Musunuru, 2013) in in vitromodels of erythropoiesis
such as human inducible pluripotent stem cells (iPSCs) (Malik
et al., 1998; Lapillonne et al., 2010; Kobari et al., 2012) may
help to identify contribution of ESE-1 in embryonic hemoglobin
synthesis.
The involvement of ESE-1 in lung development may
similarly provide a good model, given distinct pattern of
expression of ESE-1 in the human fetal lung vs. the adult
tissue, the availability of in vitro models in 3D cultures to
study branching morphogenesis from embryonic lung explants
(Warburton et al., 2005; Del Moral and Warburton, 2010),
and well-characterization of signaling pathways involved in
lung development such as FGF10 and SHH signaling (Iber
and Menshykau, 2013), which are the two most important
regulatory diffusible proteins that facilitate outgrowth of lung
buds and branching. One way to test whether Erm, an Ets
factor which was highly expressed in Elf3−/− lung (Figure 1B),
functionally compensate for the loss of Elf3 would be to generate
Elf3−/−Erm−/− double knockout and investigate the fetal lung
development. However, while mice have been used as the primary
model for the study of mammalian development given their
genetic similarity to humans, short generation time, and the
ease of gene manipulation, the human and mouse airways are
anatomically very different. For example, basal cells which are
limited to trachea in mice are present throughout the human
airways (Rock et al., 2009; Rock andHogan, 2011), and Clara cells
which are confinedmostly to distal bronchiole airways in humans
are found throughout the murine airways (Boers et al., 1999;
Rawlins et al., 2009). Therefore, another significant advantage of
studying lung morphogenesis would be the availability of human
cell models of 3D lung morphogenesis using immortalized
human bronchial epithelial cells (Franzdottir et al., 2010; Kaisani
et al., 2014), which have been shown to be multipotent (Delgado
et al., 2011), to complement the animal studies.
CONCLUDING REMARKS
The role of ESE-1 during embryogenesis had long been
implicated in previous discoveries, but there has been no in-
depth analysis of ESE-1 function in early development. With
improved proteomics and gene editing tools that are now
available, therefore, future studies which elucidate the role of
ESE-1 during embryonic development will provide not only
better insights into ESE-1 function in specific cell differentiation
pathways, but also its interactions with other Ets familymembers.
In addition, understanding how epithelium-specific Ets factors
contribute to normal embryonic development by, for example,
global gene expression analysis in systemic knockdown study
(Atabakhsh et al., 2012), will help us to better understand
how they take part in disorders and abnormalities which share
signaling pathways and gene clusters involved in embryogenesis,
such as cancer (Monk and Holding, 2001; Kim and Orkin, 2011;
Atabakhsh et al., 2012; Smith and Sturmey, 2013) and tissue
regeneration (Poss, 2010). This may open new opportunities to
tackle aberrant cell differentiation or repair mechanisms that
pose barriers to effective treatment, while building on our current
body of knowledge on how multi-member protein families
function collectively.
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